JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB137069

Anti-Arg2 antibody [EPR9473]

5

(2 Reviews)

|

(10 Publications)

Rabbit Recombinant Monoclonal Arg2 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications.

View Alternative Names

Arginase II, Kidney-type arginase, Non-hepatic arginase, Type II arginase, ARG2

8 Images
Flow Cytometry (Intracellular) - Anti-Arg2 antibody [EPR9473] (AB137069)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Arg2 antibody [EPR9473] (AB137069)

Overlay histogram showing HEK293 cells stained with ab137069 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab137069, 1/10000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in HEK293 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Immunocytochemistry/ Immunofluorescence - Anti-Arg2 antibody [EPR9473] (AB137069)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Arg2 antibody [EPR9473] (AB137069)

Immunocytochemistry/ Immunofluorescence analysis of 293T (Human embryonic kidney epithelial cell) cells labeling Arg2 with Purified ab137069 at 1 : 500 dilution (1.2 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% triton X-100. ab150077 Goat anti rabbit IgG (Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Flow Cytometry (Intracellular) - Anti-Arg2 antibody [EPR9473] (AB137069)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Arg2 antibody [EPR9473] (AB137069)

Intracellular Flow Cytometry analysis of HEK-293 (Human embryonic kidney epithelial cell) cells labeling Arg2 with purified ab137069 at 1/60 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunocytochemistry/ Immunofluorescence - Anti-Arg2 antibody [EPR9473] (AB137069)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Arg2 antibody [EPR9473] (AB137069)

Immunofluorescent analysis of Caco 2 cells labelling Arg2 with ab137069 at 1/250 dilution.

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)
  • WB

Unknown

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Arg2 antibody [EPR9473] (ab137069) at 1/10000 dilution

All lanes:

JAR (Human placenta choriocarcinoma epithelial cell) whole cell lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 39 kDa

false

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)
  • WB

Unknown

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Arg2 antibody [EPR9473] (ab137069) at 1/20000 dilution

All lanes:

Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysates at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 39 kDa

false

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)
  • WB

Unknown

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)

All lanes:

Western blot - Anti-Arg2 antibody [EPR9473] (ab137069) at 1/1000 dilution

Lane 1:

Caco 2 cell lysate at 10 µg

Lane 2:

293T cell lysate at 10 µg

Lane 3:

Jurkat cell lysate at 10 µg

Secondary

All lanes:

goat anti-rabbit HRP at 1/2000 dilution

Predicted band size: 39 kDa

true

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)
  • WB

Unknown

Western blot - Anti-Arg2 antibody [EPR9473] (AB137069)

All lanes:

Western blot - Anti-Arg2 antibody [EPR9473] (ab137069) at 1/1000 dilution

Lane 1:

GST tagged Recombinant Human ARG1 protein (full-length, aa 1 to 322) (61 KDa)

Lane 2:

GST tagged Recombinant Human ARG2 protein (full-length, aa 1 to 354) (65 KDa)

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 39 kDa

Observed band size: 65 kDa

false

  • Carrier free

    Anti-Arg2 antibody [EPR9473] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR9473

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt (Intra), ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250 - 1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/60", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody. For unpurified use at 1: 100 - 1/10000.</p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Arginase 2 (Arg2) also known as AII is an enzyme with a molecular weight of approximately 39 kDa. It is part of the urea cycle and functions to hydrolyze L-arginine into L-ornithine and urea. Arg2 is a mitochondrial enzyme mainly expressed in the liver kidney and prostate. Its expression can extend to other tissues such as the small intestine in some conditions and its activity is important in regulating arginine availability for various physiological processes.
Biological function summary

Arg2 plays a role in nitrogen disposal and polyamine synthesis. As part of an enzymatic complex it contributes to the urea cycle which is important for the removal of excess nitrogen from the body. Arginase activity also influences the balance of nitric oxide synthesis as it competes with nitric oxide synthase for their common substrate L-arginine. This competition affects cellular functions which rely on nitric oxide signaling for developing proper vascular and immune responses.

Pathways

Arg2 is an important player in the urea cycle and the polyamine synthesis pathway. It works alongside the enzymes involved in these processes such as ornithine decarboxylase. Additionally Arg2 has a role in the nitric oxide regulation pathway modulating nitric oxide levels by limiting the availability of L-arginine for nitric oxide synthase. This makes Arg2 essential for metabolic processes and cellular communication.

Altered Arg2 expression has been associated with cardiovascular diseases and renal complications. For instance disruptions in Arg2 function can lead to endothelial dysfunction influencing conditions like atherosclerosis. Arg2 imbalances are also linked to kidney diseases possibly due to its critical role in ammonia detoxification and renal arginine metabolism. Its interaction with other proteins such as nitric oxide synthase further emphasizes its relevance in these health conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

May play a role in the regulation of extra-urea cycle arginine metabolism and also in down-regulation of nitric oxide synthesis. Extrahepatic arginase functions to regulate L-arginine bioavailability to nitric oxid synthase (NOS). Arginine metabolism is a critical regulator of innate and adaptive immune responses. Seems to be involved in negative regulation of the survival capacity of activated CD4(+) and CD8(+) T cells (PubMed : 27745970). May suppress inflammation-related signaling in asthmatic airway epithelium (PubMed : 27214549). May contribute to the immune evasion of H.pylori by restricting M1 macrophage activation and polyamine metabolism (By similarity). In fetal dendritic cells may play a role in promoting immune suppression and T cell TNF production during gestation (PubMed : 28614294). Regulates RPS6KB1 signaling, which promotes endothelial cell senescence and inflammation and implicates NOS3/eNOS dysfunction (PubMed : 22928666). Can inhibit endothelial autophagy independently of its enzymatic activity implicating mTORC2 signaling (PubMed : 25484082). Involved in vascular smooth muscle cell senescence and apoptosis independently of its enzymatic activity (PubMed : 23832324). Since NOS is found in the penile corpus cavernosum smooth muscle, the clitoral corpus cavernosum and the vagina, arginase-2 plays a role in both male and female sexual arousal (PubMed : 12859189).
See full target information ARG2

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Chemical biology & drug design 105:e70147 PubMed40574308

2025

Nesfatin-1 Reduces Cholic Acid-Induced Intrahepatic Cholestasis of Pregnancy by Regulating the General Control Nonderepressible 2/Eukaryotic Initiation Factor 2α Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yong Liang,Xiaomin Wen,Zhe Sun,Yuqiong Meng,Shuhan Lv

Clinical proteomics 20:39 PubMed37749499

2023

Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization.

Applications

Unspecified application

Species

Unspecified reactive species

Ondrej Vit,Pavel Talacko,Zdenek Musil,Igor Hartmann,Karel Pacak,Jiri Petrak

Communications biology 4:1384 PubMed34893694

2021

Potent but transient immunosuppression of T-cells is a general feature of CD71 erythroid cells.

Applications

Unspecified application

Species

Unspecified reactive species

Tomasz M Grzywa,Anna Sosnowska,Zuzanna Rydzynska,Michal Lazniewski,Dariusz Plewczynski,Klaudia Klicka,Milena Malecka-Gieldowska,Anna Rodziewicz-Lurzynska,Olga Ciepiela,Magdalena Justyniarska,Paulina Pomper,Marcin M Grzybowski,Roman Blaszczyk,Michal Wegrzynowicz,Agnieszka Tomaszewska,Grzegorz Basak,Jakub Golab,Dominika Nowis

PloS one 16:e0259558 PubMed34748583

2021

NKX2-1 re-expression induces cell death through apoptosis and necrosis in dedifferentiated thyroid carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yuko Ito,Fumihiko Furuya,Katsumi Taki,Hideaki Suzuki,Hiroki Shimura

The Journal of biological chemistry 295:6263-6277 PubMed32139506

2020

Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Renee C Geck,Jackson R Foley,Tracy Murray Stewart,John M Asara,Robert A Casero,Alex Toker

JCI insight 4: PubMed31852848

2019

Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues.

Applications

Unspecified application

Species

Unspecified reactive species

Margaret M Lowe,Ian Boothby,Sean Clancy,Richard S Ahn,Wilson Liao,David N Nguyen,Kathrin Schumann,Alexander Marson,Kelly M Mahuron,Gillian A Kingsbury,Zheng Liu,Priscila Munoz Sandoval,Robert Sanchez Rodriguez,Mariela L Pauli,Keyon Taravati,Sarah T Arron,Isaac M Neuhaus,Hobart W Harris,Esther A Kim,Uk Sok Shin,Matthew F Krummel,Adil Daud,Tiffany C Scharschmidt,Michael D Rosenblum

Gastroenterology 157:1615-1629.e17 PubMed31446059

2019

New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Justin L Tan,Feng Li,Joanna Z Yeo,Kol Jia Yong,Mahmoud A Bassal,Guo Hao Ng,May Yin Lee,Chung Yan Leong,Hong Kee Tan,Chan-Shuo Wu,Bee Hui Liu,Tim H Chan,Zi Hui Tan,Yun Shen Chan,Siyu Wang,Zhi Han Lim,Tan Boon Toh,Lissa Hooi,Kia Ngee Low,Siming Ma,Nikki R Kong,Alicia J Stein,Yue Wu,Matan T Thangavelu,Atsushi Suzuki,Giridharan Periyasamy,John M Asara,Yock Young Dan,Glenn K Bonney,Edward K Chow,Guo-Dong Lu,Huck Hui Ng,Yoganathan Kanagasundaram,Siew Bee Ng,Wai Leong Tam,Daniel G Tenen,Li Chai

Cell reports 26:1691-1700.e5 PubMed30759381

2019

Mapping Metabolic Events in the Cancer Cell Cycle Reveals Arginine Catabolism in the Committed SGM Phase.

Applications

Unspecified application

Species

Unspecified reactive species

Irena Roci,Jeramie D Watrous,Kim A Lagerborg,Lorenzo Lafranchi,Arne Lindqvist,Mohit Jain,Roland Nilsson

Nature communications 8:242 PubMed28808255

2017

Critical role for arginase 2 in obesity-associated pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Tamara Zaytouni,Pei-Yun Tsai,Daniel S Hitchcock,Cory D DuBois,Elizaveta Freinkman,Lin Lin,Vicente Morales-Oyarvide,Patrick J Lenehan,Brian M Wolpin,Mari Mino-Kenudson,Eduardo M Torres,Nicholas Stylopoulos,Clary B Clish,Nada Y Kalaany

eLife 5: PubMed27336789

2016

Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

John P Vanden Heuvel,Jessica Bullenkamp
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com